Literature DB >> 28615604

A study on delay in treatment of kala-azar patients in Bangladesh.

Syed M Arif1, Ariful Basher2, Mohammad R Rahman3, Mohammad A Faiz4.   

Abstract

Visceral leishmaniasis (kala-azar) continues to be a major rural public health problem in Bangladesh. A cross-sectional study was carried out in two subdistricts of Mymensingh district from January 2006 to June 2007 to evaluate the delay kala-azar treatment. Suspected patients who attended to out patient department (OPD) were subjected to a dipstick test (RK39) for kala-azar. Sixty five from Bhaluka and 60 positive patients from Gafargaon subdistrict were enrolled. Most of the patients (80%) first visited nonqualified private practitioners, while only 15.2% consulted registered doctors. Fifty per cent were referred to the Upazilla health complex (UZHC) by the family members or relatives. About 49% and 43% patients required third and second health-care providers for kala-azar treatment, respectively. Patient delay ranged from 2 to 30 days; median 4 (IQR 3 to 7 days), the system delay ranged from 0 days to 225 days; median 54 (IQR 40-66 days). Residential status (p value <0.05) had impact on patient delay. Educational status and number of treatment providers had impact on system delay (p<0.05). System delay rather than patient delay is the important weakness of the kala-azar control programme in Bangladesh. Residence in rural areas, low educational background and treatment providers are associated with these delays. A proper educational programme may reduce the delay.

Entities:  

Year:  2012        PMID: 28615604     DOI: 10.4103/2224-3151.207041

Source DB:  PubMed          Journal:  WHO South East Asia J Public Health        ISSN: 2224-3151


  1 in total

1.  "It's just a fever": Gender based barriers to care-seeking for visceral leishmaniasis in highly endemic districts of India: A qualitative study.

Authors:  Beulah Jayakumar; Nirmala Murthy; Kingsuk Misra; Sakib Burza
Journal:  PLoS Negl Trop Dis       Date:  2019-06-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.